Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.
| Author | |
|---|---|
| Abstract |
:
Few data exist regarding use of nucleos(t)ide analogs started in early pregnancy for mothers with active chronic hepatitis B (CHB). We assessed the safety and efficacy of lamivudine/telbivudine initiated in the first trimester versus no treatment in mothers with active CHB. |
| Year of Publication |
:
2018
|
| Journal |
:
Hepatology international
|
| Date Published |
:
2018
|
| ISSN Number |
:
1936-0533
|
| URL |
:
https://dx.doi.org/10.1007/s12072-017-9839-5
|
| DOI |
:
10.1007/s12072-017-9839-5
|
| Short Title |
:
Hepatol Int
|
| Download citation |
